pI: 7.0578 |
Length (AA): 311 |
MW (Da): 34878 |
Paralog Number:
13
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130566)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G14290 | alpha/beta-hydrolase family protein |
Arabidopsis thaliana | AT4G17150 | alpha/beta-Hydrolases superfamily protein |
Arabidopsis thaliana | AT3G23540 | alpha/beta-Hydrolases superfamily protein |
Cryptosporidium hominis | Chro.70050 | random slug cDNA-11 (Fragment) |
Cryptosporidium parvum | cgd7_370 | protein with a conserved N-terminal region |
Dictyostelium discoideum | DDB_G0272791 | alpha/beta hydrolase fold-1 domain-containing protein |
Dictyostelium discoideum | DDB_G0295699 | alpha/beta hydrolase fold-1 domain-containing protein |
Leishmania braziliensis | LbrM.30.0470 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_300400.1 | Alpha/beta hydrolase family, putative |
Leishmania infantum | LinJ.30.0400 | hypothetical protein, conserved |
Leishmania major | LmjF.30.0400 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.29.0400 | hypothetical protein, conserved |
Neospora caninum | NCLIV_035460 | Alpha/beta hydrolase, related |
Oryza sativa | 9266683 | Os02g0197900 |
Oryza sativa | 4341501 | Os06g0609700 |
Plasmodium berghei | PBANKA_0707200 | alpha/beta hydrolase, putative |
Plasmodium falciparum | PF3D7_0823400 | alpha/beta hydrolase, putative |
Plasmodium knowlesi | PKNH_1317400 | alpha/beta hydrolase, putative |
Plasmodium vivax | PVX_089195 | alpha/beta hydrolase, putative |
Plasmodium yoelii | PY02678 | hypothetical protein |
Trypanosoma brucei gambiense | Tbg972.6.1510 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.6.1810 | Alpha/beta hydrolase family, putative |
Trypanosoma congolense | TcIL3000_6_1400 | Alpha/beta hydrolase family, putative |
Trypanosoma cruzi | TcCLB.511491.120 | Alpha/beta hydrolase family, putative |
Toxoplasma gondii | TGME49_271460 | protein c14orf29, putative |
Trichomonas vaginalis | TVAG_292600 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_316560 | Clan SC, family S9, unassigned serine peptidase |
Trichomonas vaginalis | TVAG_479170 | Clan SC, family S9, unassigned serine peptidase |
Trichomonas vaginalis | TVAG_329180 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_112980 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_043720 | Clan SC, family S9, unassigned serine peptidase |
Trichomonas vaginalis | TVAG_233340 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_112930 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_011790 | Clan SC, family S9, unassigned serine peptidase |
Trichomonas vaginalis | TVAG_460750 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_173950 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_374960 | Clan SC, family S33, methylesterase-like serine peptidase |
Trichomonas vaginalis | TVAG_262420 | Clan SC, family S9, unassigned serine peptidase |
Trichomonas vaginalis | TVAG_369930 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.1810 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.1810 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.1810 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.1810 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_271460 | Toxoplasma gondii | Probably non-essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Monoglyceride lipase | 303 aa | 21.2% | 250 aa | Compounds | References |